Browsing publications by Professor Graham Jackson

Newcastle AuthorsTitleYear
Professor Graham Jackson
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma2015
Dr Laura Jardine
Dr Venetia Bigley
Dr Kim Pearce
Dr Alison Dickinson
Professor Graham Jackson
et al.
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants2014
Dr Nicola Sunter
Professor Andy Hall
Dr Tryfonia Mainou-Fowler
Professor Graham Jackson
Dr James Allan
et al.
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia2014
Professor Graham Jackson
Autologous stem cell transplantation in severe treatment-resistant Crohn's disease: long-term follow-up of UK patients treated on compassionate basis2014
Professor Graham Jackson
Minimal Residual Disease: What Are the Minimum Requirements? Reply2014
Professor Graham Jackson
Optimising the use of plerixafor in stem cell mobilisation2014
Professor Graham Jackson
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results2014
Professor Graham Jackson
Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome2014
Professor Graham Jackson
The UK and Ireland Perspective: European Post-Approval Safety Study (Pass) in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide, Bortezomib, and Thalidomide2014
Kile Green
Dr Laura Jardine
Dr Kim Pearce
Dr Venetia Bigley
Professor Graham Jackson
et al.
Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study2013
12345678910111213141516171819